Sulopenem etzadroxil/probenecid
IT001-310
Phase 3 small_molecule completed
Quick answer
Sulopenem etzadroxil/probenecid for Urinary Tract Infections is a Phase 3 program (small_molecule) at Iterum Therapeutics plc with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Iterum Therapeutics plc
- Indication
- Urinary Tract Infections
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed